RTOG/NRG 1115 Quality of Life of Phase III Dose Escalated Radiation Therapy (RT) and Standard Androgen Deprivation Therapy (ADT) with GnRH Agonist vs. Dose Escalated RT and ADT with GnRH Agonist and Orteronel (TAK-700) for Men with High-Risk Prostate
| Autor: | Bruner, D.W., Pugh, S., Michaelson, D., Hamstra, D.A., Bachand, F., Master, V., Torres, M., Kaplan, I.D., Rosenthal, S.A., Roach, M., III, Raben, A., Michalski, J.M., Kavadi, V.S., Ferguson, M., Morgan, S.C., D'Souza, D.P., DeMora, L., Sandler, H.M., Movsas, B. |
|---|---|
| Zdroj: | In International Journal of Radiation Oncology, Biology, Physics 1 November 2022 114(3) Supplement:e214-e214 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|